CorMedix Inc
CRMD7.690USD
+0.340+4.63%
終値 02/06, 16:00（ET）15分遅れの株価
602.50M時価総額
3.24直近12ヶ月PER
詳細情報 CorMedix Inc 企業名
CorMedix Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases. The Company is focused on commercializing its lead product, DefenCath, which is an antimicrobial catheter lock solution approved to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure receiving chronic hemodialysis through a central venous catheter. DefenCath is a formulation of taurolidine 13.5 milligrams per milliliter (mg/mL), and heparin 1000 USP Units/mL indicated to reduce the incidence of catheter-related bloodstream infections (CRBSI) in adult patients with kidney failure receiving chronic hemodialysis through a central venous catheter (CVC). The Company is also commercializing a portfolio of anti-infective products including MINOCIN, REZZAYO, VABOMERE, ORBACTIV, BAXDELA, and KIMYRSA, as well as TOPROL-XL.
CorMedix Incの企業情報
企業コードCRMD
会社名CorMedix Inc
上場日Mar 25, 2010
最高経営責任者「CEO」Todisco (Joseph)
従業員数64
証券種類Ordinary Share
決算期末Mar 25
本社所在地300 Connell Drive
都市BERKELEY HEIGHTS
証券取引所NASDAQ OMX - NASDAQ BASIC
国United States of America
郵便番号07922
電話番号19085179500
ウェブサイトhttps://cormedix.com/
企業コードCRMD
上場日Mar 25, 2010
最高経営責任者「CEO」Todisco (Joseph)
CorMedix Incの経営陣
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Joseph (Joe) Todisco
Mr. Joseph (Joe) Todisco
Chief Executive Officer, Director
Chief Executive Officer, Director
567.46K
+77156.00%
Mr. Steven W. Lefkowitz
Mr. Steven W. Lefkowitz
Independent Director
Independent Director
133.10K
+45453.00%
Ms. Susan Blum
Ms. Susan Blum
Chief Financial Officer
Chief Financial Officer
132.74K
+63053.00%
Ms. Janet M. Dillione
Ms. Janet M. Dillione
Independent Director
Independent Director
43.93K
+20453.00%
Mr. Gregory Scott (Greg) Duncan
Mr. Gregory Scott (Greg) Duncan
Independent Director
Independent Director
43.79K
+30453.00%
Mr. Robert Stewart
Mr. Robert Stewart
Independent Director
Independent Director
41.45K
+30453.00%
Mr. Myron M. Kaplan, J.D.
Mr. Myron M. Kaplan, J.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Dr. Alan William Dunton, M.D.
Dr. Alan William Dunton, M.D.
Independent Director
Independent Director
--
--
Ms. Elizabeth (Liz) Massonhurlburt
Ms. Elizabeth (Liz) Massonhurlburt
Chief Operating Officer
Chief Operating Officer
--
--
Dr. Matthew T. (Matt) David, M.D.
Dr. Matthew T. (Matt) David, M.D.
Chief Business Officer
Chief Business Officer
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Joseph (Joe) Todisco
Mr. Joseph (Joe) Todisco
Chief Executive Officer, Director
Chief Executive Officer, Director
567.46K
+77156.00%
Mr. Steven W. Lefkowitz
Mr. Steven W. Lefkowitz
Independent Director
Independent Director
133.10K
+45453.00%
Ms. Susan Blum
Ms. Susan Blum
Chief Financial Officer
Chief Financial Officer
132.74K
+63053.00%
Ms. Janet M. Dillione
Ms. Janet M. Dillione
Independent Director
Independent Director
43.93K
+20453.00%
Mr. Gregory Scott (Greg) Duncan
Mr. Gregory Scott (Greg) Duncan
Independent Director
Independent Director
43.79K
+30453.00%
Mr. Robert Stewart
Mr. Robert Stewart
Independent Director
Independent Director
41.45K
+30453.00%
収益内訳
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
会社から関連データがまだ開示されていません。
地域別USD
会社名
収益
比率
United States
104.28M
0.00%
事業別
地域別
会社から関連データがまだ開示されていません。
株主
更新時刻: Thu, Jan 29
更新時刻: Thu, Jan 29
株主統計
種類
株主統計
株主統計
比率
BlackRock Institutional Trust Company, N.A.
6.40%
Deep Track Capital LP
6.29%
Abdalkader (Shaibatalhamd Aymen)
5.84%
The Vanguard Group, Inc.
5.69%
Marshall Wace LLP
4.41%
他の
71.37%
株主統計
株主統計
比率
BlackRock Institutional Trust Company, N.A.
6.40%
Deep Track Capital LP
6.29%
Abdalkader (Shaibatalhamd Aymen)
5.84%
The Vanguard Group, Inc.
5.69%
Marshall Wace LLP
4.41%
他の
71.37%
種類
株主統計
比率
Investment Advisor
27.93%
Hedge Fund
16.86%
Investment Advisor/Hedge Fund
15.45%
Individual Investor
8.00%
Research Firm
2.04%
Pension Fund
1.11%
Bank and Trust
0.32%
Insurance Company
0.03%
Venture Capital
0.03%
他の
28.22%
機関投資家保有株
更新時刻: Mon, Dec 8
更新時刻: Mon, Dec 8
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q4
338
43.86M
55.93%
+10.78K
2025Q3
340
43.85M
56.33%
+8.67M
2025Q2
304
34.76M
43.08%
+9.67M
2025Q1
267
24.95M
43.35%
-4.41M
2024Q4
241
23.99M
39.87%
+4.76M
2024Q3
216
19.17M
36.31%
+1.94M
2024Q2
207
17.23M
38.40%
-272.84K
2024Q1
207
17.37M
41.54%
-5.46M
2023Q4
207
18.82M
39.64%
+838.41K
2023Q3
199
17.96M
39.30%
-1.31M
詳細を見る
株主動向
会社名
保有株式数
比率
変動額
変動率
日付
BlackRock Institutional Trust Company, N.A.
5.04M
6.4%
+248.22K
+5.18%
Sep 30, 2025
Deep Track Capital LP
4.96M
6.29%
+4.46M
+891.10%
Nov 21, 2025
Abdalkader (Shaibatalhamd Aymen)
4.65M
6.22%
+4.65M
--
Aug 08, 2025
The Vanguard Group, Inc.
3.96M
5.03%
-347.89K
-8.07%
Sep 30, 2025
Marshall Wace LLP
3.47M
4.41%
+893.52K
+34.63%
Sep 30, 2025
Deerfield Management Company, L.P.
3.32M
4.22%
+3.32M
--
Sep 30, 2025
State Street Investment Management (US)
1.84M
2.33%
+233.97K
+14.61%
Sep 30, 2025
Geode Capital Management, L.L.C.
1.81M
2.3%
+213.45K
+13.37%
Sep 30, 2025
Citadel Advisors LLC
1.72M
2.18%
+2.87K
+0.17%
Sep 30, 2025
Alyeska Investment Group, L.P.
1.26M
1.6%
+512.98K
+68.40%
Sep 30, 2025
詳細を見る
関連ETF
更新時刻: Sat, Dec 6
更新時刻: Sat, Dec 6
銘柄名
比率
State Street SPDR S&P Pharmaceuticals ETF
2.01%
Invesco Biotechnology & Genome ETF
1.87%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
1.52%
VictoryShares Small Cap Free Cash Flow ETF
0.79%
First Trust Active Factor Small Cap ETF
0.3%
Janus Henderson Small Cap Growth Alpha ETF
0.25%
ALPS Barron's 400 ETF
0.21%
Janus Henderson Small/Mid Cap Growth Alpha ETF
0.19%
Vanguard US Multifactor ETF
0.16%
iShares Micro-Cap ETF
0.15%
詳細を見る
State Street SPDR S&P Pharmaceuticals ETF
比率2.01%
Invesco Biotechnology & Genome ETF
比率1.87%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
比率1.52%
VictoryShares Small Cap Free Cash Flow ETF
比率0.79%
First Trust Active Factor Small Cap ETF
比率0.3%
Janus Henderson Small Cap Growth Alpha ETF
比率0.25%
ALPS Barron's 400 ETF
比率0.21%
Janus Henderson Small/Mid Cap Growth Alpha ETF
比率0.19%
Vanguard US Multifactor ETF
比率0.16%
iShares Micro-Cap ETF
比率0.15%
配当金
過去5年間の配当金総支払額は
0.00
米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし
株式分割
日付
配当落ち日
種類
比率
データなし
日付
配当落ち日
種類
比率
データなし
